Stevanato Group S.p.A. (STVN) Revenue & Revenue Breakdown
Stevanato Group S.p.A. Revenue Highlights
Latest Revenue (Y)
$1.06B
Latest Revenue (Q)
$237.38M
Main Geography (Y)
Europe Middle East And Africa
Stevanato Group S.p.A. Revenue by Period
Stevanato Group S.p.A. Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.06B | 8.08% |
| 2022-12-31 | $983.70M | 16.57% |
| 2021-12-31 | $843.90M | 27.47% |
| 2020-12-31 | $662.04M | 23.39% |
| 2019-12-31 | $536.54M | - |
Stevanato Group S.p.A. generated $1.06B in revenue during NA 2023, up 8.08% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Stevanato Group S.p.A. Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $237.38M | -24.02% |
| 2023-12-31 | $312.41M | 15.11% |
| 2023-09-30 | $271.40M | 6.31% |
| 2023-06-30 | $255.30M | 7.27% |
| 2023-03-31 | $237.99M | -18.52% |
| 2022-12-31 | $292.10M | 19.10% |
| 2022-09-30 | $245.26M | 4.70% |
| 2022-06-30 | $234.25M | 10.46% |
| 2022-03-31 | $212.07M | -8.82% |
| 2021-12-31 | $232.60M | 8.42% |
| 2021-09-30 | $214.53M | 5.18% |
| 2021-06-30 | $203.96M | 5.76% |
| 2021-03-31 | $192.85M | -6.72% |
| 2020-12-31 | $206.74M | 31.63% |
| 2020-09-30 | $157.06M | -2.94% |
| 2020-06-30 | $161.81M | 18.60% |
| 2020-03-31 | $136.43M | - |
Stevanato Group S.p.A. generated $237.38M in revenue during Q1 2024, up -24.02% compared to the previous quarter, and up 81.27% compared to the same period a year ago.
Stevanato Group S.p.A. Revenue Breakdown
Stevanato Group S.p.A. Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| South America | $30.87M | $40.00M |
| Asia Pacific | $102.90M | $117.75M |
| Europe Middle East And Africa | $634.05M | $705.95M |
| North America | $317.54M | $294.71M |
Latest
Stevanato Group S.p.A.'s latest annual revenue breakdown by geography, as of Dec 23: Europe Middle East And Africa (58.42%), North America (29.26%), Asia Pacific (9.48%), and South America (2.84%).
Stevanato Group S.p.A. Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALC | Alcon | $10.09B | $2.46B |
| RMD | ResMed | $4.69B | $1.22B |
| XRAY | DENTSPLY SIRONA | $3.96B | $951.00M |
| COO | Cooper Companies | $3.90B | $1.00B |
| ATR | AptarGroup | $3.49B | $909.29M |
| TFX | Teleflex | $2.97B | $764.38M |
| WST | West Pharmaceutical Services | $2.95B | $746.90M |
| NVST | Envista | $2.57B | $884.70M |
| ICUI | ICU Medical | $2.26B | $589.13M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $339.85M |
| STVN | Stevanato Group S.p.A. | $1.06B | $237.38M |
| ATRC | AtriCure | $399.25M | $115.91M |
| ANGO | AngioDynamics | $303.91M | $67.49M |
| AKYA | Akoya Biosciences | $96.63M | $18.81M |